Articles

UNIDO: Long-term support for biotech yields COVID-19 vaccine promise in Cuba

UNIDO: Long-term support for biotech yields COVID-19 vaccine promise in Cuba

The Cuban government recently announced that its Soberana II vaccine against COVID-19 will soon enter Phase III trials, bringing the country one important step closer to producing Latin America’s first vaccine against the virus. Far from being an overnight success, Cuba’s ability to develop a vaccine is the result of decades-long investment in its biopharmaceutical industry, which in its early stages of development was supported by the United Nations Industrial Development Organization (UNIDO). 

Cuba deposited the instrument of ratification of the Comprehensive Nuclear-Test-Ban Treaty

Cuba deposited the instrument of ratification of the Comprehensive Nuclear-Test-Ban Treaty

New York, 4 February 2021. By signing and ratifying today the Comprehensive Nuclear-Test-Ban Treaty (CTBT), Cuba reaffirms its commitment to nuclear disarmament and to the complete and effective ban on all nuclear tests, including nuclear explosions, subcritical tests and other sophisticated methods.

With this action Cuba reaffirms its condemnation of the proliferation of subcritical tests and the increase in expenses to improve such tests. It also supports the closure and dismantling of all facilities used for such purposes and their associated infrastructure.

Cuba to deliver 1 million COVID-19 vaccine doses by April

Cuba to deliver 1 million COVID-19 vaccine doses by April

Havana (Xinhua)- Cuba could deliver the first million doses of its Soberana 02 COVID-19 vaccine candidate by late April, the country's biopharmaceutical authorities said Thursday during a televised address.

"Cuban vaccines are going well," said Eduardo Martinez, president of BioCubaFarma, a state company gathering 21 research centers and 32 companies. "Cuba will be one of the first nations to immunize its entire population."

Cuba Will Produce 100 Million Doses of Its COVID-19 Vaccine

Cuba Will Produce 100 Million Doses of Its COVID-19 Vaccine

This year, Cuba will produce 100 million doses of its new Soberana 02 coronavirus vaccine to meet its internal demand and those of other countries, a leading Cuban scientist reported on Wednesday.

"We are reorganizing our production capacities because we really have a lot of demand for the vaccine and we have to prepare ourselves," Vicente Vérez, director of the Finlay Institute, told a group of journalists at a conference in which he gave a tour of the laboratory where the vaccine against COVID-19 is manufactured.

Pages